RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Antonei Benjamin Csoka to Central Nervous System Depressants

Back to Details
This is a "connection" page, showing publications Antonei Benjamin Csoka has written about Central Nervous System Depressants.
Antonei Benjamin Csoka
Connection Strength
0.335
Central Nervous System Depressants
  1. Tizabi Y, Getachew B, Ferguson CL, Csoka AB, Thompson KM, Gomez-Paz A, Ruda-Kucerova J, Taylor RE. Low Vs. High Alcohol: Central Benefits Vs. Detriments. Neurotox Res. 2018 Nov; 34(4):860-869.
    View in: PubMed
    Score: 0.152
  2. Manavalan S, Getachew B, Manaye KF, Khundmiri SJ, Csoka AB, McKinley R, Tamas A, Reglodi D, Tizabi Y. PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity. Neurotox Res. 2017 Jul; 32(1):8-13.
    View in: PubMed
    Score: 0.144
  3. Getachew B, Hudson T, Heinbockel T, Csoka AB, Tizabi Y. Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3. Neurotox Res. 2018 Oct; 34(3):757-762.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support